Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer

Risk assessment and treatment choice remain a challenge in early non-small-cell lung cancer (NSCLC). Alternative splicing is an emerging source for diagnostic, prognostic and therapeutic tools. Here, we investigated the prognostic value of the actin cytoskeleton regulator hMENA and its isoforms, hME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Bria, Emilio, Modugno, Francesca Di, Sperduti, Isabella, Iapicca, Pierluigi, Visca, Paolo, Alessandrini, Gabriele, Antoniani, Barbara, Pilotto, Sara, Ludovini, Vienna, Vannucci, Jacopo, Bellezza, Guido, Sidoni, Angelo, Tortora, Giampaolo, Radisky, Derek C., Crinò, Lucio, Cognetti, Francesco, Facciolo, Francesco, Mottolese, Marcella, Milella, Michele, Nisticò, Paola
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Priority Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4294370/
https://ncbi.nlm.nih.gov/pubmed/25373410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados